 |
|
|
|
|
|
Name: |
|
Rose Lai MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
Columbia University Medical Center |
|
|
|
|
|
|
Location: |
|
Contact: Mahogany Ayele, RN
New York, NY USA |
|
|
|
|
Phone: |
|
212-305-2756 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
|
|
|
|
|
|
|
|
Name: |
|
Steven Rosenfeld MD |
|
|
|
|
Title: |
|
|
|
|
|
|
|
|
Facility: |
|
Columbia University Medical Center |
|
|
|
|
|
|
Location: |
|
Contact: Mary Ann Kral
New York, NY USA |
|
|
|
|
Phone: |
|
212-305-7266 |
|
|
|
|
|
|
Fax: |
|
|
|
|
|
|
Email: |
|
Click here to send an email |
|
|
|
|
|
|
Website: |
|
|
|
|
There are 5 listings:
|
|
|
|
|
|
Treatment
|
|
Location |
|
Last Updated |
|
|
|
Details |
|
Phase II Study of CDX-110 in Patients With Glioblastoma Multiforme (GBM) (ACT III) |
|
New York, NY |
|
03/09/2010 |
|
|
|
|
|
Details |
|
Phase 2 Study of Azixa (MPC-6827) for the Treatment of Patients With Recurrent Glioblastoma Multiforme |
|
New York, NY |
|
08/11/2009 |
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Malignant Glioma
|
|
New York, NY |
|
10/09/2008 |
|
|
|
|
|
Details |
|
A Phase 1, Open-Label, Dose Escalation Study of ANG1005 in Patients With Advanced Solid Tumors and Metastatic Brain Cancer |
|
New York, NY |
|
07/24/2008 |
|
|
|
Details |
|
A Phase 1/11 Study of Topotecan by Intracerebral Clysis for the Treatment of Recurrent Primary Malignant Brain Tumors |
|
NEW YORK CITY, NY |
|
08/20/2007 |
|
|
|
|
|
|
|
